Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Helsel Dave
 2. Date of Event Requiring Statement (Month/Day/Year)
01/23/2019		 3. Issuer Name and Ticker or Trading Symbol
ANGIODYNAMICS INC [ANGO]
(Last)
(First)
(Middle)
14 PLAZA DRIVE		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
SVP Global Operations and R&D
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

LATHAM, NY 12110		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 14,090 (1)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy)   (2) 12/18/2027 Common Stock 50,000 $ 17.2 D  
Non-Qualified Stock Option (right to buy)   (3) 07/18/2028 Common Stock 15,663 $ 20.93 D  
Performance Right   (4)   (4) Common Stock 10,000 $ 0 D  
Performance Right   (5)   (5) Common Stock 9,834 $ 0 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Helsel Dave
14 PLAZA DRIVE
LATHAM, NY 12110		       SVP Global Operations and R&D  

Signatures

/s/ Stephen A. Trowbridge, Attorney in Fact 02/01/2019
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) This number includes (i) 7,500 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company") underlying restricted stock units, of which 2,500 shares will vest on each of December 18, 2019, 2020 and 2021, and (ii) 4,916 shares of Common Stock of the Company underlying restricted stock units, of which 1,228 shares will vest on each of July 18, 2019 and 2020, and 1,230 shares will vest on each of July 18, 2021 and 2022.
(2) These stock options vest in four annual installments beginning on December 18, 2018, such that 12,500 options vested on December 18, 2018, and 12,500 options will vest on each of December 18, 2019, 2020 and 2021.
(3) These stock options vest in four annual installments beginning on July 18, 2019, such that 3,916 options will vest on each of July 18, 2019, 2020 and 2021, and 3,915 options will vest on July 18, 2022.
(4) Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in column 3 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited.
(5) Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in column 3 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Any shares that do not vest at the end of the performance period will be forfeited.
 
Remarks:
Exhibit List:  Exhibit 24.1 - Power of Attorney

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.